Pharmacokinetic considerations for enhancing drug repurposing opportunities of anthelmintics: Niclosamide as a case study
Recently, anthelmintics have showcased versatile therapeutic potential in addressing various diseases, positioning them as promising candidates for drug repurposing. However, challenges such as low bioavailability and a lack of a solid pharmacokinetic basis impede successful repurposing. To overcome...
Main Authors: | Jeong In Seo, Geun-woo Jin, Hye Hyun Yoo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332224002786 |
Similar Items
-
Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug
by: Junyi Ren, et al.
Published: (2022-11-01) -
Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
by: Linjuan Huang, et al.
Published: (2023-07-01) -
Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide
by: Udayan Bhattacharya, et al.
Published: (2023-01-01) -
In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment
by: Jesse W. Wotring, et al.
Published: (2022-08-01) -
A Repurposed Drug Screen for Compounds Regulating Aquaporin 5 Stability in Lung Epithelial Cells
by: John Villandre, et al.
Published: (2022-01-01)